Allscripts Announces Allscripts eRecruit, New Initiative to Improve Population Health

AllscriptsAllscripts (NASDAQ:MDRX) announced today its latest initiative to improve population health, Allscripts eRecruitTM services. This multi-faceted initiative will offer services and technology to support physicians with referring patients to clinical trials, and life sciences and clinical research organizations to reduce clinical studies' time and cost. This, in turn will help bring new treatments to the market more quickly.

Allscripts eRecruit, the initial offering of Allscripts Clinical Trials Solutions, enables more effective clinical trials recruitment from Allscripts broad provider network and large patient population. eRecruit focuses specifically on helping CROs determine if a trial is feasible within the Allscripts population, and facilitating enrollment of the qualified patients the trial requires. The solution also assists with recruiting patients to participate in these studies through engagements with their providers. This offering provides an avenue for clinical research and life sciences organizations to better recruit for treatment research, providers to find relevant clinical trials for their patients, and patients to engage in innovative care.

Allscripts is partnering with ePatientFinder® to further eRecruit's patient matching, outreach and recruiting capabilities. The ePatientFinder Clinical Trial ExchangeTM platform helps physicians learn about the latest clinical trial options for their patients to provide high-quality referrals.

"We very excited to partner with Allscripts to provide their large provider base access to the Clinical Trial Exchange, the only platform of its kind that leverages the trusted physician-patient relationship and EHR data to match patients with trials for advanced care," said Tom Dorsett, CEO of ePatientFinder. "We applaud Allscripts for bringing eRecruit to both the provider and life-science communities."

"Allscripts eRecruit is the latest way that Allscripts is connecting communities to foster population health," said Jay Bhattacharyya, Allscripts Vice President and General Manager, Payer/Life Sciences. "Providers want to keep up with the latest research that helps improve patient outcomes. eRecruit helps providers better connect their patients to these clinical trials. We are excited to continue to expand our offerings in this space and lead the way in population health innovation."

About Allscripts
Allscripts (NASDAQ:MDRX) is a leader in healthcare information technology solutions that advance clinical, financial and operational results. Our innovative solutions connect people, places and data across an Open, Connected Community of HealthTM. Connectivity empowers caregivers to make better decisions and deliver better care for healthier populations. To learn more, visit www.allscripts.com, Twitter, YouTube and It Takes A Community: The Allscripts Blog.

Most Popular Now

Unlocking the 10 Year Health Plan

The government's plan for the NHS is a huge document. Jane Stephenson, chief executive of SPARK TSL, argues the key to unlocking its digital ambitions is to consider what it...

Alcidion Grows Top Talent in the UK, wit…

Alcidion has today announced the addition of three new appointments to their UK-based team, with one internal promotion and two external recruits. Dr Paul Deffley has been announced as the...

New Training Year Starts at Siemens Heal…

In September, 197 school graduates will start their vocational training or dual studies in Germany at Siemens Healthineers. 117 apprentices and 80 dual students will begin their careers at Siemens...

AI can Find Cancer Pathologists Miss

Men assessed as healthy after a pathologist analyses their tissue sample may still have an early form of prostate cancer. Using AI, researchers at Uppsala University have been able to...

AI, Full Automation could Expand Artific…

Automated insulin delivery (AID) systems such as the UVA Health-developed artificial pancreas could help more type 1 diabetes patients if the devices become fully automated, according to a new review...

How AI could Speed the Development of RN…

Using artificial intelligence (AI), MIT researchers have come up with a new way to design nanoparticles that can more efficiently deliver RNA vaccines and other types of RNA therapies. After training...

MIT Researchers Use Generative AI to Des…

With help from artificial intelligence, MIT researchers have designed novel antibiotics that can combat two hard-to-treat infections: drug-resistant Neisseria gonorrhoeae and multi-drug-resistant Staphylococcus aureus (MRSA). Using generative AI algorithms, the research...

AI Hybrid Strategy Improves Mammogram In…

A hybrid reading strategy for screening mammography, developed by Dutch researchers and deployed retrospectively to more than 40,000 exams, reduced radiologist workload by 38% without changing recall or cancer detection...

Are You Eligible for a Clinical Trial? C…

A new study in the academic journal Machine Learning: Health discovers that ChatGPT can accelerate patient screening for clinical trials, showing promise in reducing delays and improving trial success rates. Researchers...

Global Study Reveals How Patients View M…

How physicians feel about artificial intelligence (AI) in medicine has been studied many times. But what do patients think? A team led by researchers at the Technical University of Munich...

New AI Tool Addresses Accuracy and Fairn…

A team of researchers at the Icahn School of Medicine at Mount Sinai has developed a new method to identify and reduce biases in datasets used to train machine-learning algorithms...

AI Analysis of Colonoscopy Improves Asse…

In a new study, artificial intelligence (AI) matched and potentially exceeded the performance of gastroenterologists and conventional scoring in evaluating endoscopies of Crohn’s disease patients. The results, published in Clinical Gastroenterology...